Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed Shengir

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
World Journal of Gastroenterology|May 19, 2021
Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyondMohamed Shengir, Mohamed Elgara, Giada Sebastiani
Current HIV/AIDS Reports|September 28, 2020
NASH in HIVAdriana Cervo, Mohamed Shengir, Keyur Patel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 15, 2021
FIB-4 Improves LSM-Based Prediction of Complications in Overweight or Obese Patients With Compensated Advanced Chronic Liver DiseaseYuly P Mendoza, Mohamed Shengir, Jaime Bosch, et al.
World Journal of Gastroenterology|December 14, 2020
Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndromeMohamed Shengir, Srinivasan Krishnamurthy, Peter Ghali, et al.
Canadian Liver Journal|July 18, 2025
Validation of FIB-4 for the Diagnosis of Liver Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver DiseaseChinmay Bera, Nashla Hamdan-Perez, Heather Mary-Kathleen Kosick, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2023
Increased Serum Fibroblast Growth Factor 23 Predicts Mortality in People With HIV/HCV CoinfectionMohamed Shengir, Carine Fillebeen, John Wagner, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 16, 2021
Non-alcoholic fatty liver disease in premenopausal women with polycystic ovary syndrome: A systematic review and meta-analysisMohamed Shengir, Tianyan Chen, Elena Guadagno, et al.
Scientific Reports|July 8, 2025
Machine learning models using non-invasive tests & B-mode ultrasound to predict liver-related outcomes in metabolic dysfunction-associated steatotic liver diseaseHeather Mary-Kathleen Kosick, Chris McIntosh, Chinmay Bera, et al.
Clinics and Research in Hepatology and Gastroenterology|June 18, 2025
Metabolic factors drive early increase in hepatic steatosis despite improvement in non-invasive fibrosis markers after hepatitis C eradication with direct-acting antiviralsMohamed Shengir, Wesal Elgretli, Felice Cinque, et al.
HIV Medicine|August 29, 2023
Switch to a raltegravir-based antiretroviral regimen in people with HIV and non-alcoholic fatty liver disease: A randomized controlled trialMohamed Shengir, Bertrand Lebouche, Wesal Elgretli, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
World Journal of Gastroenterology|May 19, 2021
Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyondMohamed Shengir, Mohamed Elgara, Giada Sebastiani
Current HIV/AIDS Reports|September 28, 2020
NASH in HIVAdriana Cervo, Mohamed Shengir, Keyur Patel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 15, 2021
FIB-4 Improves LSM-Based Prediction of Complications in Overweight or Obese Patients With Compensated Advanced Chronic Liver DiseaseYuly P Mendoza, Mohamed Shengir, Jaime Bosch, et al.
World Journal of Gastroenterology|December 14, 2020
Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndromeMohamed Shengir, Srinivasan Krishnamurthy, Peter Ghali, et al.
Canadian Liver Journal|July 18, 2025
Validation of FIB-4 for the Diagnosis of Liver Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver DiseaseChinmay Bera, Nashla Hamdan-Perez, Heather Mary-Kathleen Kosick, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2023
Increased Serum Fibroblast Growth Factor 23 Predicts Mortality in People With HIV/HCV CoinfectionMohamed Shengir, Carine Fillebeen, John Wagner, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 16, 2021
Non-alcoholic fatty liver disease in premenopausal women with polycystic ovary syndrome: A systematic review and meta-analysisMohamed Shengir, Tianyan Chen, Elena Guadagno, et al.
Scientific Reports|July 8, 2025
Machine learning models using non-invasive tests & B-mode ultrasound to predict liver-related outcomes in metabolic dysfunction-associated steatotic liver diseaseHeather Mary-Kathleen Kosick, Chris McIntosh, Chinmay Bera, et al.
Clinics and Research in Hepatology and Gastroenterology|June 18, 2025
Metabolic factors drive early increase in hepatic steatosis despite improvement in non-invasive fibrosis markers after hepatitis C eradication with direct-acting antiviralsMohamed Shengir, Wesal Elgretli, Felice Cinque, et al.
HIV Medicine|August 29, 2023
Switch to a raltegravir-based antiretroviral regimen in people with HIV and non-alcoholic fatty liver disease: A randomized controlled trialMohamed Shengir, Bertrand Lebouche, Wesal Elgretli, et al.
Pageof 2